Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03874884
Title 177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer (LuPARP)
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia
Indications

prostate adenocarcinoma

Therapies

lutetium Lu 177 vipivotide tetraxetan + Olaparib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.